Because anaerobic bacteria cause significant human infections that require specific therapy and because anaerobes are resistant to certain antimicrobials, the isolation, identification, and determination of antimicrobial susceptibilities are as important for these bacteria as they are for other pathogenic bacteria. Anaerobic culturing can be made cost-efficient by strict adherence to several principles, including the selective culturing of only appropriate general specimens that are uncontaminated by normal flora (this can be achieved by educating physicians and nurses in recognizing likely sources of anaerobic infection); rapid transport of specimens and use of appropriate transport systems; use of a system of rejection and notification when inappropriate or when multiple specimens have been received; and use of a logical algorithm for determining the degree of isolation and identification to be performed, according to the numbers and types of organisms present. Testing of all significant gram-negative organisms for the production of b-lactamases can provide an early indication of antimicrobial susceptibility, and actual testing limited to screening of three or four drugs can be performed on selected isolates by using a rapid and simple method such as the Etest (AB BIODISK, Solna, Sweden). Although the number of anaerobic bacteremias has declined since the 1970s, this number has plateaued in recent years, and these infections are life-threatening. Routine culturing of blood for anaerobes is still indicated in many institutions because of the unpredictable clinical sources of some bacteremias and the improved yields of both anaerobes and some streptococci when anaerobic blood culture systems are used.
In an era of cost containment, there is a tendency for laborabic infections can have dire consequences; (4) broad-spectrum empirical antimicrobial therapy is expensive, may not be effectories to cut back on the performance of those tests that are considered more ''esoteric'' than others, especially if they are tive, and promotes the development of resistance to antimicrobials; and (5) resistance to antimicrobials is prevalent among costly to perform; anaerobic culturing and identification might be considered to be in this category by some laboratory personanaerobes and is increasing; susceptibility patterns among certain anaerobes are much less predictable than they used to be. nel. However, the worth of a test should be measured by its diagnostic and therapeutic value to the physician and the paIn spite of these facts, the real value of anaerobic culturing may be difficult to determine. One major reason for this difficulty tient. The cost of doing anaerobic cultures must be balanced by the potential costs of not doing them -i.e., misdiagnosis is that anaerobic infections are often actually mixed infections involving a number of anaerobic, facultative, and aerobic bacteand mistreatment, leading to prolonged morbidity and hospitalization and even death.
ria. It may be difficult to determine which organisms are playing a primary role, and a response to antimicrobial therapy may be Ample literature (including the proceedings of two prior symposia [1, 2] like this one) has accumulated over the past difficult to interpret because of the important role of surgery in many cases and the fact that multiple organisms may be suscepti-20 years, and the following findings have been documented: (1) anaerobes are significant causes of human infections; (2) ble to the antimicrobial(s) used. Therefore, it is only reasonable to allow the clinicians to determine how valuable anaerobic culanaerobic infections are associated with significant morbidity and mortality; (3) improper diagnosis and treatment of anaeroturing will be to them in relation to the anticipated antimicrobial and surgical therapy and allow them to selectively order anaerobic cultures when they believe these cultures are needed (an exception is the routine performance of anaerobic blood cultures, which will be discussed later). It is incumbent upon laboratory Laboratories can make anaerobic culturing more cost-effi-A recent review of 1 month's experience at the Mayo Clinic (Rochester, MN) showed that Ç15% of specimens submitted cient by adhering to the following principles: (1) perform selective rather than routine culturing on the basis of specific orders for anaerobic culturing were rejected by the laboratory. Most of these specimens (56%) were inappropriately collected and from physicians; (2) restrict culturing to those specimens collected so as to avoid contamination with the abundant normal were swabs. The next most frequent problem (13% of specimens) was that specimens were collected from sites normally anaerobic flora of the body; (3) use specimen transport methods that will preserve the anaerobic bacteria and prevent the prolifcolonized by anaerobes (i.e., the vagina or upper respiratory tract). Seven percent of specimens were rejected because the eration of the less fastidious facultative organisms that may be present; (4) use ''rejection criteria,'' which will prevent the source itself was inappropriate (i.e., stool or voided urine). Six percent of rejected specimens had been mistakenly ordered for culturing of specimens that do not meet standards specified in items (2) and (3) above; (4) use a selective approach to the culture. In the majority of these cases of rejected specimens, the clinician concluded that there was no need to have an analysis of the culture that is based on the kind and number of isolates present and the specimen type; (5) identify isolates to anaerobic culture done after all, and there was no confrontation with the laboratory. the level useful to the physician by using rapid and inexpensive methods; and (6) selectively provide cost-efficient and useful Laboratory personnel may also want to communicate with physicians who submit multiple specimens from the same site antimicrobial susceptibility information, including the results of b-lactamase testing as well as actual susceptibility testing, (these are usually surgical specimens, frequently from patients with orthopedic conditions) at the same time. It should be as rapidly as possible.
pointed out that cultures of such specimens almost always yield the same results and are very expensive to perform. A solution Specimen Selection and Collection to the possible argument by a clinician that there may be different organisms in the different sampling areas of the same site The types of infections in which anaerobes often play a role, the types of specimens that are acceptable for culture, and would be to offer to pool the samples into one culture, thereby efficiently screening for all organisms present. suitable methods of collection have been extensively discussed and well described in the past [3, 4] and will not be discussed further herein. Several adequate anaerobic transporters are Culture and Identification commercially available; those requiring the use of swabs should be avoided, since swab specimens are rarely, if ever, adequate.
Cost-effective anaerobic bacteriology requires that specimens be processed as efficiently as possible. Use of selective Stringent anaerobic culturing requires that abundant amounts of purulent fluid that is not contaminated with normal flora be and differential media is essential, and these media include bacteroides bile-esculin (BBE) agar, laked kanamycin-vancoobtained by needle aspiration. It is simply too easy to collect inadequate and/or contaminated specimens with a swab and/or mycin (LKV) blood agar, and phenylethyl alcohol blood agar [4] . Use of these media allows rapid detection and separation to transport them suboptimally. Surgical tissue specimens are suitable and may simply be placed in rubber (removable) -of anaerobes from facultative organisms in the mixed flora that often is present. Anaerobic culturing can be adequately carried stoppered tubes that have been gassed out with carbon dioxide. Anaerobes in these specimens are likely to be protected by the out by using anaerobic jars, but quality control measures must be applied to ensure that jar lids and catalysts are functioning reduced environment within the infected tissue.
In the current era, laboratory personnel should develop criteproperly. Although many anaerobes will grow within 24 hours of incubation, 48 hours are probably required to ensure that ria for rejecting specimens that are not adequate for anaerobic culturing. This is best done by obtaining the input of clinicians all organisms are recovered. Some more-fastidious organisms, such as species of Porphyromonas, may require 5 -7 days of who are knowledgeable about infectious diseases and by conveying an attitude of cooperation and helpfulness rather than incubation. Pigment production may also require longer periods of incubation. While anaerobic glove boxes may be useful in confrontation. Clinicians should understand that a rejection policy will improve the quality of results reported to them and certain circumstances, they are not essential for general anaerobic bacteriology, and the lack of these devices should not disimprove efficiency in the laboratory. Clinicians should be notified promptly and given a logical reason when a specimen is courage laboratory personnel from performing these cultures. The extent of efforts to isolate and identify anaerobes should rejected, and they should be provided an opportunity to respond before the specimen is discarded. This communication should be based on the growth on the primary culture plates. If five or more anaerobes appear to be present (and there are usually be informative and educational rather than punitive. ''Precious'' specimens (CSF, joint fluids, other normally sterile multiple facultative organisms in such cultures as well), there is usually no benefit to the clinician in identifying individual body fluids obtained by needle aspiration, and tissues and/or fluids obtained during surgery) should never be discarded withisolates, and a report of mixed flora may be sent. If one isolate type appears to predominate, laboratory personnel may choose out culturing before discussion with the clinician. S129 CID 1997;25 (Suppl 2)
Cost of Anaerobic Cultures to identify only this isolate, especially if a ''partial identificaindicate that even in a referral laboratory setting, the evaluation of anaerobic cultures and identification procedures may be eftion'' or ''rapid identification'' scheme can be used and if a clinically significant and potentially resistant member of the ficiently streamlined. ''Bacteroides fragilis group'' is suspected. If the culture contains more than two anaerobes (or more than a total of three organisms), partial identifications may be performed -i.e., the Cost of Anaerobic Cultures identification is limited to subculture for confirmation that the organisms are obligate anaerobes and to description by gram How cost-efficient is culturing of anaerobes, even when policies that streamline the process are used? As previously menstaining only (e.g., an anaerobic gram-positive bacillus). If cultural and microscopic morphologies suggest a genus, that tioned, any conclusions drawn from analysis of these data must be tempered by consideration of the costs in terms of both notation may also be added (i.e., ''. . . resembling Clostridium, Fusobacterium, Prevotella (Bacteroides) melaninogenica money and the patient morbidity that may result if these cultures are not performed. Such costs are difficult to estimate but group [if pigmented], etc.''). A rapid b-lactamase test (Cefinase, BBL Microbiology Systems, Cockeysville, MD) should are potentially great, considering that even one additional day in an intensive care unit for treatment of an incorrectly diagalso be performed on all gram-negative bacilli, and the result included (i.e., ''anaerobic gram-negative bacillus, b-lactamase nosed infection can cost many thousands of dollars. Rough calculations based on the estimated laboratory costs of Current positive''). Even this limited information may be useful to the clinician in mapping a strategy for treating a mixed infection Procedural Terminology (CPT) -coded procedures performed at the Mayo Clinic and on the usual Midwestern market fees due to multiple organisms.
More-complete identifications should be as rapid and abbre-(as determined by Mayo Medical Laboratory surveys) for these tests suggest that a small profit (Ç$3.00) can be made on viated as possible. Clostridium perfringens can be identified on the basis of microscopic morphology, the presence of a cultures that do not yield anaerobes or from which only mixed floras are reported (i.e., no processing beyond culture, incubadouble zone of hemolysis surrounding colonies on blood agar, and lecithinase production on egg-yolk agar. The ''B. fragilis tion, and inspection of the plates is done). A somewhat greater profit (Ç$10 -$15) can be made from partial identification of group'' can be identified by typical growth on BBE and LKV agars, diagnostic disk antibiograms, and b-lactamase producanaerobic isolates. This is counterbalanced by losses of $10 -$13 per identification of isolates with use of a rapid kit alone tion. It may seldom be necessary for most clinical laboratories to identify anaerobic cocci to a level beyond the organisms ' and losses of $4 -$5 per isolate when additional tests, including GLC, are performed. The fact that Medicare reimbursement is cultural and gram-stain characteristics, and such isolates could legitimately be reported at the genus level (i.e., ''Peptostreptoconsiderably lower than market fees must also be taken into consideration. coccus'' or ''Veillonella'').
Most complete identifications to the species level can be Obviously, the balance figure for performing anaerobic cultures and identifications will vary considerably depending on achieved by using simple and rapid kits that detect preformed enzymes and that are commercially available (AnIdent [Analythe yield of the cultures, the degree to which the isolates are identified, and the amount of Medicare reimbursement retab Products, Plainview, NY] or the RapID-ANA II System [Innovative Diagnostic Systems, Atlanta]). These kits are comceived. Given all of these factors, it was possible to estimate that a laboratory that processed 750 anaerobic cultures per parable in performance and cost (Ç$5 -$6 per individual test strip). Many clinical laboratories will not pursue difficult identimonth, most of which required minimal processing and most of which yielded isolates that were only partially identified or fications beyond this stage; an incomplete identification plus antimicrobial susceptibility results, when indicated, will suffice identified with use of rapid kits alone, could realize a profit of $1,000 -$2,000, providing Medicare reimbursement reprein most clinical situations.
Difficult identifications may be pursued in referral laborasented only a small portion of the fees collected. These calculations are so general and speculative that they tories with use of additional rapid biochemical kits (e.g., Minitek; BBL) and gas-liquid chromatography (GLC). A recent may be difficult to apply to any individual laboratory. However, they do suggest that anaerobic culturing need not be considered review of our experience at the Mayo Clinic Anaerobe Laboratory (which I would classify as a referral laboratory) indicates too costly for the average laboratory to perform or even necessarily a money-losing activity. Indeed, it is even likely that that of the cultures that yielded anaerobes, 19% were reported only as mixed flora. For the other cultures from which isolates small profits can be made if proper principles of specimen selection and collection are adhered to and the streamlined were identified, 52% of the isolates were reported as partial identifications, and 48% were reported as more complete identiprocessing described above is used. While the proper provision of clinically useful culture results should be the overriding fications. Approximately 80% of the isolates in the latter group required only use of a rapid kit for identification, whereas 20% principle of every anaerobe laboratory, avoidance of monetary losses or even generation of small profits will help keep costrequired additional biochemical and/or GLC testing. These data / 9c36$$se63 08-11-97 18:36:43 cidas UC: CID cific results for current isolates provide a rationale for this approach. In addition, knowledge of specific susceptibilities of For anaerobic gram-negative bacilli an anaerobe can lead to substantial cost savings in treatment.
• ter Pharmacy).
Anaerobic Blood Cultures conscious administrators from the door and ensure the continuation of this vital activity.
The need to perform routine anaerobic blood cultures has become a particularly contentious issue (except in the case of children, where there is a consensus that such cultures should Antimicrobial Susceptibility Testing not be performed routinely). During the 1970s, anaerobic bacteremias accounted for as much as 25% of all bacteremias at Antimicrobial susceptibility testing of clinical anaerobic isolates can also be made cost-efficient by streamlining the prosome medical centers. However, in recent years that number has dropped dramatically and is as low as £1% in some institucess. Because of the increasing unpredictability of susceptibility patterns and the desire on the part of clinicians to be aware tions [6] , although at many centers it is more likely 3% -5% [7, 8] . At the Mayo Clinic, the average number of such bacterof all susceptibility results for patients who are critically ill, timely testing should be available for anaerobes isolated from emias per year dropped from 117 in 1974 -1978 to 58 in 1989 -1993 and has remained steady at the latter figure since then. the following sites: blood and other normally sterile body fluids, bones and joints, surgical tissues, and needle aspirates from There has been a call to discontinue the routine performance of anaerobic blood cultures and depend on selective schemes, any closed abscess. Testing for b-lactamase production should be performed on all gram-negative bacilli and may be used in such as requiring a specific order by clinicians when they recognize a typical setting for anaerobic infection or culturing blood the testing algorithm outlined (in table 1 ).
The Etest (AB BIODISK, Solna, Sweden) is an efficient from patients most likely to develop anaerobic infection, such as those being treated by surgeons or obstetricians-gynecolomethod for testing clinical isolates because of its great flexibility [5] . Even though the individual antimicrobial strips are gists [6, 9] . The problem with this approach is that now a significant costly (Ç$2 per strip), the ability to place up to four strips on a single agar plate and design a logical and efficient process number of atypical anaerobic infections occur that would not have been predicted by many physicians. Recent studies have (such as that outlined in table 1) makes the entire procedure relatively inexpensive (Ç$30 per organism). The Etest is also found that 16% -28% of anaerobic bacteremias would not have been predicted by ordering physicians because these bactermore practical than agar dilution, which requires a minimum of 15 -20 organisms in a batch to be cost-effective, and more emias originated from unsuspected sources, and many of the patients had malignancies and/or were immunosuppressed [8, flexible than broth microdilution, in which numerous antimicrobials are included on each microplate. The cost of these plates 10]. Our own estimate at the Mayo Clinic is that Ç50% of the anaerobic bacteremias that occurred in 1995 -1996 would not will vary considerably, depending on whether they are prepared in-house or purchased commercially.
have been predicted. In addition, experience at several institutions where experiments with selective ordering by physicians Other antimicrobials may be added if an organism is resistant to multiple agents or if a clinician wishes to use another agent.
or based on the type of hospital service were performed has shown that this approach failed to accurately target the approAll antimicrobials tested should have had susceptibility breakpoints and quality control MIC ranges determined for priate patients. Furthermore, two studies conducted at Mayo institutions indicated that, with the blood culture systems studa standard set of anaerobes, as established by the National Committee on Clinical Laboratory Standards (NCCLS; see ied, not only were anaerobes recovered at a higher rate in the anaerobic bottles, but the rate of recovery of some streptococci NCCLS Document M11 -A3). While some laboratorians may disagree with testing some anaerobes and antimicrobials for was also higher [11, 12] . In one of these studies, the optimum recovery of all organisms was achieved with a combination which the susceptibility patterns are considered predictable,
